SAGALATIN

This brand name is authorized in South Africa

Active ingredients

The drug SAGALATIN contains one active pharmaceutical ingredient (API):

1 Dapagliflozin UNII 887K2391VH - DAPAGLIFLOZIN PROPANEDIOL

Dapagliflozin is a highly potent, selective and reversible inhibitor of SGLT2. SGLT2 is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Dapagliflozin improves both fasting and post-prandial plasma glucose levels by reducing renal glucose reabsorption leading to urinary glucose excretion. Read about Dapagliflozin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SAGALATIN Film-coated tablet	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BK01	Dapagliflozin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors
Discover more medicines within A10BK01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ZA	Health Products Regulatory Authority	Identifier(s): 53/21.1/0720, 53/21.1/0721